Literature DB >> 20372955

Correlation between the VITEK2 system and cefoxitin disk diffusion for the daily detection of oxacillin resistance in a large number of clinical Staphylococcus aureus isolates.

P Bemer1, M E Juvin, G Le Gargasson, H Drugeon, A Reynaud, S Corvec.   

Abstract

The aim of the present study was to compare the performance of the new VITEK2 AST-P551 card with the cefoxitin disk diffusion method for the daily detection of methicillin resistance with a high number of Staphylococcus aureus clinical isolates. Detection of the PBP2a protein or mecA gene was performed for each discordant case. Seventy (3.3%) isolates out of 2,107 clinical strains showed discordant results, two very major errors, four major errors and 64 minor errors. Fifty-nine (84%) discordant results were resolved, with a final overall agreement of 99.5%. Eleven (0.5%) strains remained discordant (minor error [mE]). Four of 370 MRSA strains were misclassified as susceptible in daily practice by the cefoxitin disk diffusion method. All of these strains were resistant to aminoglycosides and/or fluoroquinolones. The VITEK2 system is highly reliable for methicillin resistance detection at the routine level. Oxacillin-susceptible classified clinical strains with associated resistance patterns required attention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372955     DOI: 10.1007/s10096-010-0920-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

1.  Evaluation of the vitek 2 AST-P559 card for detection of oxacillin resistance in Staphylococcus aureus.

Authors:  Eva Torres; Sonia Pérez; Rosa Villanueva; Germán Bou
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

2.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs.

Authors:  Jana M Swenson; David Lonsway; Sigrid McAllister; Angela Thompson; Laura Jevitt; Wenming Zhu; Jean B Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2007-01-19       Impact factor: 2.803

4.  Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA.

Authors:  N B Frebourg; D Nouet; L Lemée; E Martin; J F Lemeland
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Sudha Pottumarthy; Thomas R Fritsche; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2005-01       Impact factor: 2.803

6.  Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus.

Authors:  R Skov; R Smyth; M Clausen; A R Larsen; N Frimodt-Møller; B Olsson-Liljequist; G Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2003-07-01       Impact factor: 5.790

7.  Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test.

Authors:  Annie Felten; Bernadette Grandry; Philippe Henri Lagrange; Isabelle Casin
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

8.  Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin.

Authors:  Sandrine Roisin; Claire Nonhoff; Olivier Denis; Marc J Struelens
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.